BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 27, 2022
View Archived Issues
Ginisortamab restores gremlin-1-ablated BMP signaling in CRC cell lines
Read More
Novel murine model may shed light for future strategies for aggressive glioblastoma
Read More
Servier patents new MAT2A inhibitors
Read More
Sumitomo Pharma divulges Chk1 inhibitors
Read More
Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer
Read More
SAGE Therapeutics describes new GABA-A receptor modulators
Read More
Merck & Co. identifies new GLCT-1 inhibitors
Read More
Tokyo University of Science discloses LXR antagonists
Read More
Silo in commercial evaluation license agreement for next-generation liposomes for autoimmune disease
Read More
Dual CXCR4/ACKR3 inhibitor in combination with ICT impedes 4T1 tumor growth and metastasis
Read More
FDA clears Fusion's IND applications for FPI-2059 and imaging analogue FPI-2058
Read More
[89Zr]-Labeled antibody targeting glypican-1 developed as theranostic for pancreatic cancer
Read More
First preclinical data on NR2F6 antagonist TES-4207
Read More
Molecular signature predicts cancer risk in patients with NAFLD
Read More
Voltron initiates preclinical study of vaccine candidate VTX-067 in immune-oncology model
Read More
SAN-903 dampens renal fibrosis in mouse model of chronic kidney disease
Read More
Evaxion to advance EVX-03 into clinic for NSCLC
Read More
Brilacidin inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants in vitro
Read More
Soligenix reports 100% protection in NHPs with bivalent vaccine against MARV and SUDV
Read More